US Stock Market Move | New wave of infections of COVID-19 reappears, Moderna (MRNA.US)
As of the time of writing, the stock has risen by more than 4%, reaching $25.90.
On Monday, Moderna's stock price (MRNA.US) rose, with the stock soaring over 4% to $25.9 by the time of publication. In terms of news, a new wave of the epidemic is spreading quickly in the Asian region. According to data from the Chinese Center for Disease Control and Prevention, the new wave of the epidemic may reach the peak levels seen last summer. Dr. Xu Deyi, head of the Hong Kong Health Protection Center, stated at a press conference that in the coming weeks, the level of COVID-19 activity is expected to remain at a high level.
RECOMMEND
